St. Jude Medical (St. Paul, Minnesota) reported that an interim analysis of its FAME II trial has found highly statistically significant reduction in the need for hospital readmission and urgent revascularization when Fractional Flow Reserve (FFR)-guided assessment was used to direct treatment in patients with coronary artery disease. Read More
